HMOX1 and Obesity: Therefore, HO‐1 inducer‐loaded PBP‐NPs were considered to be novel therapeutics for obesity‐induced metabolic syndromes such as T2DM and NASH occurred by adipose tissue dysfunction with excessive NEFA, inflammation, and oxidative stress.